PROMIS NEUROSCIENCES INC. Earnings Per Share (Basic)
PROMIS NEUROSCIENCES INC. (PMN) reported Earnings Per Share (Basic) of -$1.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- PROMIS NEUROSCIENCES INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.28.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.26.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.10, a 2682.72% increase year-over-year.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.24, a 177.42% decline year-over-year.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for fiscal 2025 was -$22.61, a 943.66% decline from fiscal 2024.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for fiscal 2024 was $2.68.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for fiscal 2023 was -$1.07.
- PROMIS NEUROSCIENCES INC. earnings per share, basic for fiscal 2022 was -$2.41.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.28 10-Q · filed 2026-08-13 | -$2.54 10-Q · filed 2026-08-13 | $1.04 derived: net income ÷ weighted average shares · filed 2026-08-13 | $4.25 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$1.26 10-Q · filed 2026-05-12 | $0.39 derived: net income ÷ weighted average shares · filed 2026-05-12 | $1.87 derived: net income ÷ weighted average shares · filed 2026-05-12 | $3.42 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2026-03-25 | $0.80 derived: net income ÷ weighted average shares · filed 2026-03-25 | $1.80 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$22.61 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$0.24 10-Q · filed 2025-11-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.78 10-Q · filed 2025-11-12 | $8.95 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$7.26 10-Q · filed 2026-08-13 | -$0.29 10-Q · filed 2025-08-13 | -$12.53 10-Q · filed 2026-08-13 | -$0.50 10-Q · filed 2025-08-13 | $0.86 derived: net income ÷ weighted average shares · filed 2026-08-13 | $1.06 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-03-31 | -$5.27 10-Q · filed 2026-05-12 | -$0.21 10-Q · filed 2025-05-12 | $0.24 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-05-12 | $0.28 derived: net income ÷ weighted average shares · filed 2026-05-12 | |||
| 2024-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-03-25 | $2.68 10-K · filed 2026-03-25 | $0.11 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $0.31 10-Q · filed 2025-11-12 | $0.27 derived: net income ÷ weighted average shares · filed 2025-11-12 | $0.13 10-Q · filed 2025-11-12 | -$0.03 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.13 10-Q · filed 2025-08-13 | -$0.32 10-Q · filed 2025-08-13 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-08-13 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-08-13 | ||||
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$0.79 derived: net income ÷ weighted average shares · filed 2025-05-12 | ||||
| 2023-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.07 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.19 10-Q · filed 2024-11-14 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.98 10-Q · filed 2024-11-14 | $2.03 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.27 10-Q · filed 2024-08-08 | -$0.85 10-Q · filed 2024-08-08 | $2.53 derived: net income ÷ weighted average shares · filed 2024-08-08 | $1.91 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||||
| 2023-03-31 | -$0.58 10-Q · filed 2024-05-14 | $2.81 derived: net income ÷ weighted average shares · filed 2024-05-14 | $2.22 derived: net income ÷ weighted average shares · filed 2024-05-14 | $1.94 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||
| 2022-12-31 | $3.43 derived: net income ÷ weighted average shares · filed 2024-04-01 | $2.93 derived: net income ÷ weighted average shares · filed 2024-04-01 | $2.65 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$2.41 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$0.83 10-Q · filed 2023-11-14 | -$0.85 10-Q · filed 2022-11-14 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.50 10-Q · filed 2023-11-14 | -$1.51 10-Q · filed 2022-11-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-14 | -$0.67 10-Q · filed 2023-08-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.29 10-Q · filed 2023-05-15 | $0.01 derived: net income ÷ weighted average shares · filed 2023-05-15 | $0.18 derived: net income ÷ weighted average shares · filed 2023-05-15 | |||||
| 2021-12-31 | $0.30 derived: net income ÷ weighted average shares · filed 2023-03-08 | $0.50 derived: net income ÷ weighted average shares · filed 2023-03-08 | -$1.69 10-K · filed 2023-03-08 | |||||
| 2021-09-30 | -$0.20 10-Q · filed 2022-11-14 | -$1.44 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.06 10-Q · filed 2022-08-12 | -$1.30 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |